Boc-D-FMK

Boc-D-FMK, or tert-Butyloxycarbonyl-Asp(OMe)-fluoromethyl ketone, is a synthetic peptide-based inhibitor widely recognized in biochemical research for its potent and selective inhibition of caspase family proteases. As a derivative of the aspartic acid fluoromethyl ketone scaffold, it features a Boc-protected N-terminus, conferring stability and facilitating its use in diverse experimental settings. Its ability to covalently modify the active site cysteine of caspases makes it an indispensable tool for probing apoptotic pathways and dissecting protease-mediated cellular processes. Researchers value Boc-D-FMK for its specificity, membrane permeability, and utility in mechanistic studies of programmed cell death.

Apoptosis research: In studies focused on programmed cell death, Boc-D-FMK serves as a reliable irreversible inhibitor of caspases, particularly caspase-3 and related enzymes. By covalently binding to the active site cysteine residue, it effectively blocks proteolytic activity, enabling researchers to dissect the contribution of caspase-dependent pathways in apoptosis. This application is fundamental for elucidating the molecular underpinnings of cell death in response to various stimuli, as well as for distinguishing between caspase-dependent and -independent mechanisms.

Protease activity assays: The compound is frequently employed in in vitro and cell-based assays to validate the specificity of caspase substrates and to confirm the involvement of aspartate-directed cysteine proteases in proteolytic cascades. By selectively inhibiting these enzymes, Boc-D-FMK allows for precise measurement of caspase activity, facilitating the characterization of enzyme kinetics, substrate preferences, and the identification of novel protease targets in complex biological samples.

Cell signaling pathway analysis: In the context of signal transduction studies, Boc-D-FMK is utilized to interrogate the role of caspases within broader cellular networks. Its application allows investigators to parse the downstream effects of caspase inhibition on signaling pathways, gene expression profiles, and the regulation of key cellular events such as inflammation, differentiation, and cell cycle progression. This targeted approach aids in clarifying the interplay between proteolytic activity and cellular signaling dynamics.

Peptide inhibitor design and validation: Boc-D-FMK's well-defined structure and mechanism of action make it a valuable reference compound in the development and benchmarking of novel peptide-based protease inhibitors. Researchers use it as a standard to assess the potency, selectivity, and cellular permeability of new inhibitor candidates. Its established performance in biochemical assays provides a reliable baseline for comparative studies, supporting the advancement of next-generation caspase inhibitors and related research tools.

Mechanistic studies of cell fate: The use of Boc-D-FMK extends to experimental models aimed at unraveling the molecular determinants of cell survival and death. By modulating caspase activity, it enables the investigation of upstream and downstream effectors involved in cell fate decisions. Such studies are instrumental in advancing the understanding of cellular responses to stress, toxic insults, and developmental cues, thereby contributing to knowledge of fundamental biological processes and the identification of novel molecular targets.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes